Global Health Ltd. (MEDANTA) Share Price Falls 3.32% Today: Price Action, Sector and Peer Analysis
- August 11, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Ltd. Share Price Today fell 3.32% to Rs 1,426.75, taking MEDANTA into focus as a large-cap top decliner with a market capitalisation of Rs 39,120.84 crore.
Global Health Ltd. Share Price was under pressure on 11 August 2026, with the stock falling to Rs 1,426.75, down Rs 49.05 or 3.32% from the previous close of Rs 1,475.80. With a market capitalisation of Rs 39,120.84 crore, MEDANTA drew attention in Stock Market Today as a large-cap counter that moved sharply enough to qualify under its event threshold.
For investors tracking Global Health Ltd. Share Price Today, the verified data establishes a clear same-day price fall but does not establish a company-specific catalyst. That makes the move relevant because it was not just a marginal decline. The stock opened at Rs 1,473.95, touched an intraday high of Rs 1,482.25 and then fell to a low of Rs 1,424 before trading near that weaker end of the range in afternoon trade.
Global Health Ltd. Stock News is therefore being driven by price action, trading participation and market context rather than any confirmed company announcement in the supplied data. Total traded volume stood at 2,40,519 shares, including BSE volume of 1,05,778 and NSE volume of 1,34,741, while turnover was Rs 15.09 crore.
For readers searching Global Health Ltd. Share Price, Why Is Global Health Ltd. Falling Today, or Global Health Ltd. Share Price Fall, the key points are straightforward: the stock declined 3.32%, cleared the qualifying bar for its Large Cap category, remains far larger than the typical company in its Healthcare benchmark set, and now deserves closer attention through sector and peer comparison. Univest examines that broader context below.
Global Health Ltd. (MEDANTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,426.75 |
| Previous Close | Rs 1,475.8 |
| Today's Change | Rs -49.05 (-3.32%) |
| Day Open | Rs 1,473.95 |
| Day High | Rs 1,482.25 |
| Day Low | Rs 1,424 |
| Current Volume (BSE) | 1,05,778 |
| BSE Traded Volume | 1,05,778 |
| NSE Traded Volume | 1,34,741 |
| Combined NSE + BSE Volume | 2,40,519 |
| Turnover | Rs 15.09 crore |
| Market Capitalisation | Rs 39,120.84 crore |
| Market Cap Category | Large Cap |
Global Health Ltd. (MEDANTA) traded at Rs 1,426.75. versus the previous close of Rs 1,475.8, a fall of 3.32%. The stock opened at Rs 1,473.95, reached Rs 1,482.25, touched Rs 1,424. Reported volume was 1,05,778.
Global Health Ltd. (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 39,120.84 crore |
Global Health Ltd. Share Price is attracting attention mainly because the stock is a large-cap name with a market capitalisation of Rs 39,120.84 crore, which places it in a very different size bracket from most companies in the supplied Healthcare benchmark. That size alone does not indicate quality, but it does matter when investors assess how unusual a single-day decline is for a stock of this scale.
The most important fundamental context available in the supplied data is comparative rather than standalone. Within the Healthcare sector snapshot, the benchmark scope is the same sector and it covers 197 companies. Across that set, the median market capitalisation is Rs 142.30 crore and the average market capitalisation is Rs 472.15 crore, with a minimum of Rs 4.08 crore and a maximum of Rs 3,032.97 crore. Against that backdrop, Global Health Ltd. Market Cap of Rs 39,120.84 crore is dramatically above both the median and average and even well above the maximum company market cap shown in the benchmark sample.
That matters for Global Health Ltd. Fundamental Analysis because a large-cap hospital and healthcare services company often gets watched differently from smaller healthcare counters. Even without a supplied P/E ratio, P/B ratio, ROE, ROCE, EPS, book value or dividend yield for the company, the market value still offers a useful signal: this is not a small speculative counter experiencing a random fluctuation. It is a sizeable listed business whose single-session share price fall was strong enough to enter Market Movers discussions.
The turnover of Rs 15.09 crore and total volume of 2,40,519 shares also add a practical market-quality lens to the price move. A decline in a stock of this size with visible exchange participation on both BSE and NSE tends to be monitored closely in Global Health Ltd. Stock Analysis and Global Health Ltd. Company News coverage. In short, the supplied fundamentals do not provide a full profitability or valuation profile, but they do confirm that the stock’s scale makes this price action worth tracking. That naturally leads into who the company is being compared with in the market.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 25.7x |
| Benchmark Average P/E | 96.66x |
| Benchmark P/E Range | 3.08x to 3,396.3x |
| Benchmark Median P/B | 1.94x |
| Benchmark Median ROE | 10.92% |
| Benchmark Median ROCE | 13.38% |
| Company Market Capitalisation | Rs 39,120.84 crore |
| Benchmark Median Market Cap | Rs 142.3 crore |
Global Health Ltd. (MEDANTA) is classified under sector: Healthcare.
Track today’s top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Global Health Ltd. Share Price sits within the Healthcare sector, and the benchmark data shows a sector with wide valuation dispersion. The same-sector sample covers 197 companies, making the comparison broad enough to show how varied healthcare valuations and return ratios can be.
For sector analysis, the first takeaway is how broad the Healthcare valuation range is. The benchmark includes 197 companies in the same sector. Among 156 companies with P/E data, the median P/E is 25.70 and the average P/E is 96.66, while the range stretches from 3.08 to 3,396.30. That wide spread suggests a sector where earnings multiples can vary sharply depending on business model, profitability profile and market expectations. Global Health Ltd. Share Price therefore needs to be viewed in a sector that already contains both low-multiple and very high-multiple businesses.
The P/B dataset covers 196 companies and shows a median of 1.94 and an average of 2.65, with values ranging from -16.90 to 15.98. Return ratios also vary meaningfully. For 196 companies, the median ROE is 10.92% and the average ROE is 15.47%. The median ROCE is 13.38% and the average ROCE is 17.78%. These figures indicate that Healthcare is not a monolithic sector; instead, it includes businesses generating widely different profitability levels.
Market-cap data further underlines that point. Across 197 companies, the median market capitalisation is Rs 142.30 crore and the average is Rs 472.15 crore, while the minimum is Rs 4.08 crore and the maximum is Rs 3,032.97 crore. By comparison, Global Health Ltd. Share Price reflects a company with a market capitalisation of Rs 39,120.84 crore, which is far beyond the upper end of this supplied benchmark set. That does not explain today’s decline by itself, but it does show why MEDANTA tends to stand apart from the typical listed healthcare name.
Industry context within the benchmark is also mixed. Most benchmark companies listed in the snapshot are in Pharmaceuticals & Drugs, while Dr Agarwals Eye Hospital Ltd. appears under Hospital & Healthcare Services. That makes Global Health Ltd. Share Price especially relevant for investors who want to separate hospital-led business models from pharmaceutical peers when reading Global Health Ltd. Latest News on Univest.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 3,032.97 | 0 | 0.76 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,799.54 | 0 | 2.32 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,707.2 | 40.09 | 9.77 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,631.45 | 66.92 | 10.59 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,601.85 | 34.14 | 7.04 | -2.6 | 16.92 |
Global Health Ltd. (MEDANTA) has a market capitalisation of Rs 39,120.84 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Global Health Ltd. Share Price is difficult to compare on a like-for-like basis using the supplied peers because the peer list is dominated by Pharmaceuticals & Drugs companies, while one visible healthcare services comparator is Dr Agarwals Eye Hospital Ltd. Even so, the figures still help frame the stock’s relative size and the valuation environment around it.
Among the supplied companies, Dishman Carbogen Amcis Ltd. has a market cap of Rs 3,032.97 crore with a P/B of 0.76, ROE of -2.89% and ROCE of -0.26%. Hikal Ltd. stands at Rs 2,799.54 crore with P/B of 2.32, ROE of 15.22% and ROCE of 16.15%. Kwality Pharmaceuticals Ltd. has a market cap of Rs 2,707.20 crore, P/E of 40.09, P/B of 9.77, ROE of 28.21% and ROCE of 26.35%. Beta Drugs Ltd. is valued at Rs 2,631.45 crore with P/E of 66.92, P/B of 10.59, ROE of 18.65% and ROCE of 22.17%.
The closest business-type reference in the supplied set is Dr Agarwals Eye Hospital Ltd., which has a market cap of Rs 2,601.85 crore, P/E of 34.14, P/B of 7.04, ROE of -2.60% and ROCE of 16.92%. Panacea Biotec Ltd. comes in at Rs 2,531.49 crore with P/B of 8.67, ROE of 0 and ROCE of 5.36%. Sai Parenteral’s Ltd. stands at Rs 2,513.58 crore with P/E of 181.97, P/B of 3.36, ROE of 13.90% and ROCE of 12.97%. Solara Active Pharma Sciences Ltd. has a market cap of Rs 2,422.79 crore, P/B of 1.93, ROE of 17.23% and ROCE of 15.34%.
NGL Fine-Chem Ltd. is at Rs 2,118.60 crore with P/E of 44.48, P/B of 6.50, ROE of 27.90% and ROCE of 33.91%, while Venus Remedies Ltd. is valued at Rs 2,068.61 crore with P/E of 17.49, P/B of 2.96, ROE of 9.85% and ROCE of 7.89%.
The most obvious conclusion is scale. Global Health Ltd. Share Price corresponds to a market capitalisation of Rs 39,120.84 crore, making it far larger than every supplied peer. For investors following Global Health Ltd. Share News, that means peer ratios may provide sector colour, but size and business-model differences remain important when interpreting today’s weakness.
Why Investors Are Watching Global Health Ltd.
Global Health Ltd. Share Price is being watched because today’s move was significant enough to qualify as a screened price fall in a large-cap stock. The decline was visible across the session, supported by cash-market activity and accompanied by a market value that is far above the typical company in the supplied Healthcare benchmark. In short, the stock is trending because the move was large enough to matter, even though the supplied data does not identify a company-specific catalyst.
- Price action: The stock fell 3.32% or Rs 49.05 to Rs 1,426.75 from a previous close of Rs 1,475.80.
- Intraday behaviour: After opening at Rs 1,473.95 and touching Rs 1,482.25, the stock declined to Rs 1,424, showing sustained weakness.
- Participation: Total volume stood at 2,40,519 shares, with 1,05,778 on BSE and 1,34,741 on NSE; turnover was Rs 15.09 crore.
- Category relevance: MEDANTA is a Large Cap stock, and its 3.
- Sector position: Its market capitalisation of Rs 39,120.84 crore is far above the Healthcare benchmark median of Rs 142.30 crore and average of Rs 472.15 crore.
Going forward, investors tracking Global Health Ltd. Share Price Today may want to monitor whether the stock stabilises away from the day low of Rs 1,424, how future sessions compare with today’s turnover and volume participation, and whether company-specific updates emerge in Global Health Ltd. Stock News. Univest will continue to place those market moves in a broader sector and peer framework rather than reading an unsupported cause into a single trading session.
About Global Health Ltd.
Global Health Ltd. operates within the Healthcare sector, and the supplied market context places it alongside hospital, healthcare services and pharmaceutical businesses tracked on Indian exchanges. The stock trades under the symbol MEDANTA, a name widely followed by market participants looking at hospital-linked listed companies.
From an industry comparison perspective, the supplied benchmark set shows that healthcare is a broad listed space rather than a single uniform business bucket. Many names in the benchmark and peer set are classified under Pharmaceuticals & Drugs, while Dr Agarwals Eye Hospital Ltd. appears under Hospital & Healthcare Services. That distinction matters when readers search Global Health Ltd. Share Price, Global Health Ltd. NSE, Global Health Ltd. BSE or Global Health Ltd. Company News, because healthcare services businesses are often assessed on a different operating profile from drug manufacturers.
What stands out most from the verified data is not a descriptive business segment breakdown, but the company’s scale in the listed market. With a market capitalisation of Rs 39,120.84 crore, Global Health Ltd. is substantially larger than the market-cap figures shown for the supplied healthcare comparables. That larger listed presence is one reason Global Health Ltd. Share Price Live moves attract attention quickly in Market News and Stock Updates. On days like today, when the stock records a notable decline and enters the Top Losers Today conversation, that scale makes the move especially relevant for investors, analysts and traders following the Indian Stock Market on Univest.
Track Global Health Ltd. Share Price on Univest
Use Global Health Ltd. (MEDANTA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.
Readers who want to follow Global Health Ltd. Share Price more closely can use Univest to monitor live share price moves, day highs and lows, market capitalisation, 52-week levels, sector context and broader stock analysis. Global Health Ltd. Share Price Today can look very different when seen only as a percentage change versus when it is placed beside turnover, exchange volumes, sector benchmarks and peer metrics.
Univest helps organise those data points in one place so users can track Global Health Ltd. Stock News, Global Health Ltd. Share Price Update, peer comparison, valuation ratios where available, shareholding pattern when disclosed, and market insights linked to NSE News and BSE News. For a stock like MEDANTA, which can draw attention quickly during sessions of market decline, that consolidated view can help investors separate a verified price event from unsupported speculation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Global Health Ltd. Share Price falling today?
Ans. Global Health Ltd. Share Price fell 3.32% to Rs 1,426.75 from Rs 1,475.80. The supplied data confirms the price event and trading activity, but it does not establish a company-specific catalyst behind today’s decline.
What is the Global Health Ltd. Share Price Today?
Ans. Global Health Ltd. Share Price Today is Rs 1,426.75. The stock was down Rs 49.05 on the day, after opening at Rs 1,473.95 and trading within an intraday range of Rs 1,482.25 to Rs 1,424.
How much did MEDANTA fall in today’s trade?
Ans. MEDANTA declined by Rs 49.05 or 3.32% versus its previous close of Rs 1,475.80. That move was large enough to place the stock among the notable top decliner names being tracked today.
What were the day high and day low for Global Health Ltd.?
Ans. Global Health Ltd. traded at a day high of Rs 1,482.25 and a day low of Rs 1,424. The current price of Rs 1,426.75 shows the stock was trading close to the lower end of that range.
What was the opening price of Global Health Ltd. stock today?
Ans. Global Health Ltd. opened at Rs 1,473.95, very close to its previous close of Rs 1,475.80. The stock briefly touched Rs 1,482.25 before weaker intraday price action pushed it down to Rs 1,424.
What is the market capitalisation of Global Health Ltd.?
Ans. Global Health Ltd. has a market capitalisation of Rs 39,120.84 crore. That is far above the Healthcare benchmark median of Rs 142.30 crore and average of Rs 472.15 crore in the supplied sector snapshot.
Why did this decline qualify for a price-fall screen?
Ans. The stock belongs to the Large Cap category and fell 3.32% today. Share Price coverage.
What volume was traded in Global Health Ltd. today?
Ans. Total traded volume in Global Health Ltd. was 2,40,519 shares. That included 1,05,778 shares on BSE and 1,34,741 shares on NSE, while reported turnover for the session stood at Rs 15.09 crore.
Which sector does Global Health Ltd. belong to?
Ans. Global Health Ltd. belongs to the Healthcare sector. The supplied benchmark covers 197 same-sector companies, with P/E data for 156 companies and profitability data for 196 companies across the comparison set.
How does Global Health Ltd. compare with the supplied peers?
Ans. On market capitalisation, Global Health Ltd. is much larger than the supplied peers, which range from Rs 2,068.61 crore to Rs 3,032.97 crore. The peer list also spans both hospital services and pharmaceuticals businesses.
